Shawn P Kubli

Company: Treadwell Therapeutics

Job title: Co-Founder, Director of Cell Therapy

Seminars:

Mediating Translation of Natural TCR for Optimal Efficacy of TCR-T 4:30 pm

Integrating functional HTS with in silico analyses to accelerate TCR and cognate p-HLA discovery Leveraging reductionist in vitro analytics to stratify TCR dependent impacts to TCR-T functional output/performance Linking TCR-dependent variation in signaling during early activation of TCR-T to drug product persistenceRead more

day: DAY ONE TRACK 4 B